254 related articles for article (PubMed ID: 7925387)
21. Derivatives of blood coagulation factor IX contain a high affinity Ca2+-binding site that lacks gamma-carboxyglutamic acid.
Morita T; Isaacs BS; Esmon CT; Johnson AE
J Biol Chem; 1984 May; 259(9):5698-704. PubMed ID: 6425296
[TBL] [Abstract][Full Text] [Related]
22. The gamma-carboxyglutamic acid and epidermal growth factor-like modules of factor IXa beta. Effects on the serine protease module and factor X activation.
Astermark J; Hogg PJ; Stenflo J
J Biol Chem; 1994 Feb; 269(5):3682-9. PubMed ID: 8106413
[TBL] [Abstract][Full Text] [Related]
23. Anticoagulant and antithrombotic properties of a gamma-carboxyglutamic acid-rich peptide derived from the light chain of blood coagulation factor X.
Nawroth PP; Kisiel W; Stern DM
Thromb Res; 1986 Dec; 44(5):625-37. PubMed ID: 3810564
[TBL] [Abstract][Full Text] [Related]
24. Comparison of lipid binding and kinetic properties of normal, variant, and gamma-carboxyglutamic acid modified human factor IX and factor IXa.
Jones ME; Griffith MJ; Monroe DM; Roberts HR; Lentz BR
Biochemistry; 1985 Dec; 24(27):8064-9. PubMed ID: 3879187
[TBL] [Abstract][Full Text] [Related]
25. Molecular cloning of glycoprotein Ib-binding protein, flavocetin-A, which inhibits platelet aggregation.
Shin Y; Okuyama I; Hasegawa J; Morita T
Thromb Res; 2000 Aug; 99(3):239-47. PubMed ID: 10942790
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of Mg2+- and Ca2+-bound Gla domain of factor IX complexed with binding protein.
Shikamoto Y; Morita T; Fujimoto Z; Mizuno H
J Biol Chem; 2003 Jun; 278(26):24090-4. PubMed ID: 12695512
[TBL] [Abstract][Full Text] [Related]
27. Baculovirus-mediated expression of the epidermal growth factor-like modules of human factor IX fused to the factor XIIIa transamidation site in fibronectin. Evidence for a direct interaction between the NH2-terminal epidermal growth factor-like module of factor IXa beta and factor X.
Astermark J; Sottile J; Mosher DF; Stenflo J
J Biol Chem; 1994 Feb; 269(5):3690-7. PubMed ID: 7906269
[TBL] [Abstract][Full Text] [Related]
28. Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X.
Mizuno H; Fujimoto Z; Atoda H; Morita T
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7230-4. PubMed ID: 11404471
[TBL] [Abstract][Full Text] [Related]
29. Cloning and characterization of a blood coagulation factor IX-binding protein from the venom of Trimeresurus stejnegeri.
Lee WH; Zhuang QY; Zhang Y
Toxicon; 2003 Jun; 41(7):765-72. PubMed ID: 12782076
[TBL] [Abstract][Full Text] [Related]
30. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
[TBL] [Abstract][Full Text] [Related]
31. Effects of gamma-carboxyglutamic acid and epidermal growth factor-like modules of factor IX on factor X activation. Studies using proteolytic fragments of bovine factor IX.
Astermark J; Hogg PJ; Björk I; Stenflo J
J Biol Chem; 1992 Feb; 267(5):3249-56. PubMed ID: 1737781
[TBL] [Abstract][Full Text] [Related]
32. Binding of Ca2+ and Zn2+ to factor IX/X-binding protein from venom of Agkistrodon halys Pallas: stabilization of the structure during GdnHCl-induced and thermally induced denaturation.
Wu H; Xu X; Shen D; Peng L; Song J; Zhang Y
J Biol Inorg Chem; 2011 Jan; 16(1):69-79. PubMed ID: 20830601
[TBL] [Abstract][Full Text] [Related]
33. Regulation of the tertiary structure and function of coagulation factor IX by magnesium (II) ions.
Sekiya F; Yamashita T; Atoda H; Komiyama Y; Morita T
J Biol Chem; 1995 Jun; 270(24):14325-31. PubMed ID: 7782291
[TBL] [Abstract][Full Text] [Related]
34. Membrane binding properties of the factor IX gamma-carboxyglutamic acid-rich domain prepared by chemical synthesis.
Jacobs M; Freedman SJ; Furie BC; Furie B
J Biol Chem; 1994 Oct; 269(41):25494-501. PubMed ID: 7929250
[TBL] [Abstract][Full Text] [Related]
35. Residues Phe342-Asn346 of activated coagulation factor IX contribute to the interaction with low density lipoprotein receptor-related protein.
Rohlena J; Kolkman JA; Boertjes RC; Mertens K; Lenting PJ
J Biol Chem; 2003 Mar; 278(11):9394-401. PubMed ID: 12522212
[TBL] [Abstract][Full Text] [Related]
36. Functional and sequence characterization of coagulation factor IX/factor X-binding protein from the venom of Echis carinatus leucogaster.
Chen YL; Tsai IH
Biochemistry; 1996 Apr; 35(16):5264-71. PubMed ID: 8611513
[TBL] [Abstract][Full Text] [Related]
37. Structural requirements for Ca2+ binding to the gamma-carboxyglutamic acid and epidermal growth factor-like regions of factor IX. Studies using intact domains isolated from controlled proteolytic digests of bovine factor IX.
Astermark J; Björk I; Ohlin AK; Stenflo J
J Biol Chem; 1991 Feb; 266(4):2430-7. PubMed ID: 1989994
[TBL] [Abstract][Full Text] [Related]
38. High-affinity, specific factor IXa binding to platelets is mediated in part by residues 3-11.
Ahmad SS; Rawala-Sheikh R; Cheung WF; Jameson BA; Stafford DW; Walsh PN
Biochemistry; 1994 Oct; 33(40):12048-55. PubMed ID: 7918424
[TBL] [Abstract][Full Text] [Related]
39. Crystallization and preliminary X-ray study of blood coagulation factor IX/factor X-binding protein with anticoagulant activity from Habu snake venom.
Mizuno H; Atoda H; Morita T
J Mol Biol; 1991 Jul; 220(2):225-6. PubMed ID: 1856859
[TBL] [Abstract][Full Text] [Related]
40. Comparison of coagulation factor Xa and des-(1-44)factor Xa in the assembly of prothrombinase.
Skogen WF; Esmon CT; Cox AC
J Biol Chem; 1984 Feb; 259(4):2306-10. PubMed ID: 6698966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
